The article points to people with elevated fasting glucose, significant insulin resistance and preserved pancreatic beta-cell function, the profile where metformin's insulin-sensitizing action has something to work on
For people with intestinal disease: If you have certain intestinal diseases, such as inflammatory bowel disease, colonic ulceration, or partial intestinal obstruction, or if youre predisposed to intestinal obstruction, you shouldnt take acarbose
and serves on a speaker's bureau for AstraZeneca, Novo Nordisk, Eli Lilly, Sanofi, Merck Sharp & Dohme, Boehringer Ingelheim and Janssen
This has been investigated in 708 T2DM patients, mean age 57 years-old, 66% women, with a mean duration of diabetes of 7 years attending a diabetes conference in several cities in USA
It's the chemically chopped up version of normal lecithin